Abstract:Objective To express and analyze the physical and chemical characterizations of recombinant human serum albumin/granulocyte colony-stimulating factor fusion protein for making protein drugs.Methods The genetically engineered yeast Pichia pastoris strains used in the expression of rHSA/GCSF fusion proteins was constructed.The fusion protein was directly secreted by yeast into a simple non-organic culture medium,and then purified by a three-step highly-efficient chromatography.The physical and chemical characterizations of the highly purified drug-level fusion protein were investigated in detail.Results The obtained fusion protein purity is more than 98%.The first 15 amino acids of the N-terminal sequence of the fusion protein match that of the predicted sequence,with the molecular mass of Maldi-TOF/TOF spectrum being 85305 D and closed to the predicted 85215 D for rHSA/GCSF.UV-circular dichroism (CD) spectra is not different compared with HSA or GCSF,and fusion protein’s IEF (pI) is around 5.8.The fusion proteins are non-glycoprotein with staining,and UV-wavelength specification shows typical protein spectroscopy.The 2.4 measurement of free-sulfhydryl (SH) group matchs the predicted value;and mass spectrometric peptide mapping shows 84% identity to the predicted peptide fragments.The residues in the bulk preparations are also investigated and meet the standard requirement,including the endotoxin,host protein,exogenous DNA,methanol and glycerol.The immune-identification is positive and the bio-assay in vitro is 1.5 × 107 IU/mg,with no difference seen between rhGCSF and fusion protein in equimolar amounts.Conclusions The methods used and results obtained from this study may be used as qualification standards in making the clinically available final products of long acting protein drug "Recombinant human serum albumin/granulocyte stimulating factor fusion protein for injection".

Expression, Purification, And Lipolytic Activity Of Recombinant Human Serum Albumin Fusion Proteins With One Domain Of Human Growth Hormone In Pichia Pastoris

In Vivo Bioassay of Recombinant Human Growth Hormone Synthesized Inb. Moripupae

Engineering of a Pichia pastoris Expression System for High-Level Secretion of HSA/GH Fusion Protein

Development and Characterization of a Novel Fusion Protein of a Mutated Granulocyte Colony-Stimulating Factor and Human Serum Albumin in Pichia Pastoris.

High-level secretory expression, purification and characterization of Ailuropoda melanoleuca growth hormone in Pichia pastoris.

High Level Expression and Purification of Recombinant Human Serum Albumin in Pichia Pastoris.

Construction,expression and Characterization of Recombinant Fusion Protein HSA-PTH(1-34) in Pichia Pastoris

Expression of Human Globular Adiponectin-Glucagon-like Peptide-1 Analog Fusion Protein and Its Assay of Glucose-Lowering Effect in Vivo.

RSM optimization of HSA/IL1Ra in Pichia pastoris overexpression strain and study of its in vivo activity in reducing hyperglycemia of GK rats.

The Effect of Gene Copy Number and Co-Expression of Chaperone on Production of Albumin Fusion Proteins in Pichia Pastoris.

One-Step Purification of a Fusion Protein of Glucagon-Like Peptide-1 and Human Serum Albumin Expressed in Pichia pastoris by an Immunomagnetic Separation Technique

High-Level Soluble Expression of Higf-1 Fusion Protein in Recombinant Escherichia Coli

Medium Optimization for High Yield Production of Human Serum Albumin in Pichia Pastoris and Its Efficient Purification

Precise and Combinatorial PEGylation Generates a Low-Immunogenic and Stable Form of Human Growth Hormone

Metabolomic Differential Compounds Reflecting the Clinical Efficacy of Polyethylene Glycol Recombinant Human Growth Hormone in the Treatment of Childhood Growth Hormone Deficiency

Expression and the physical and chemical characterizations studies of recombinant human serum albumin/granulocyte colony-stimulating factor fusion protein with long-acting bio-function

A Cell-Based Strategy for Bioactivity Determination of Long-Acting Fc-Fusion Recombinant Human Growth Hormone

Functional Human Antibody CDR Fusions As Long-Acting Therapeutic Endocrine Agonists

Lipidation-dimerization Platform Unlocks Treatment Potential of Fibroblast Growth Factor 21 for Non-Alcoholic Steatohepatitis

Disruption of YPS1 and PEP4 genes reduces proteolytic degradation of secreted HSA/PTH in Pichia pastoris GS115

Preparation and Characterization of A Novel Exendin-4 Human Serum Albumin Fusion Protein Expressed in Pichia Pastoris